|Videos|September 14, 2015
Varying Levels of Information in the Treatment of Colorectal Cancer
Advertisement
Episodes in this series
Different patients want different levels of information, says John L. Marshall, chief, Division of Hematology/Oncology, Georgetown University Hospital, associate director, Clinical Research, Lombardi Comprehensive Cancer Center.
Though some patients want to see scans, blood tests, biopsy information and more, they need to know that it may be difficult to understand. Other patients, he says, just want to know about the next treatment steps.
Advertisement
Related to this article
Three phase 3 trials presented at the 2026 ESMO Congress looked closely at swallowing, daily functioning and blood counts in throat, kidney and colorectal cancer. Here is what they found about living well during and after treatment.
Longer follow-up presented at the 2026 ESMO Congress showed that four already-approved treatments for early breast cancer, kidney cancer, colorectal cancer and stomach and esophageal cancer kept helping patients years later.
Advertisement
Advertisement
Trending on CURE
1
Precision Radiation Cuts 1-Year Pancreatic Cancer Recurrence to 20.2%
2
5 Years of Pancreatic Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
3
The Breast Cancer Test Many Patients Don’t Know to Ask For
4
3 Prostate Cancer Results From ESMO 2026 Patients Should Know
5